Thursday, October 15, 2015 12:29:19 PM
The new trial protocol has been submitted to the FDA. 35 sites are in the process of being set up in the U.S and Europe. Now that the news has spread, VTL is heading back to the $12 to $18 area that it had in the latter stages of the prior trial. I don't see it pushing 30 again until we get the first positive result. Options players believe this is going to $10 by tomorrow (options expiration). Don't know that it will move that fast, but fair value right now is about $12, with a move toward the $15-$18 range as the 4th quarter goes on, as we will be much closer to the first subject being enrolled. This stock will fly on any positive data! Happy to be in this. Good luck to all longs
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM